A

nd so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans and we are optimistic about our agenda. We are taking in another installment in our “Let’s-see-them-before-they-die” concert series and plan to take the short person in search of the Great Pumpkin. We will, of course, also take some naps. But what about you? Those of you with yards could get some exercise by raking leaves or, if you prefer, ignore the mess and take a drive to watch the leaves fall elsewhere. Any distraction from the current state of affairs may be a good thing. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The Ontario government is investigating allegations that Teva Pharmaceuticals (TEVA) offered pharmacies “illegal” payments to stock its opioid medications fentanyl and oxycodone, The Toronto Star reports. The newspaper obtained emails showing a Teva corporate accounts manager offering to pay an Ontario pharmacy group a rate of 15 percent of the drug price if it stocked the prescription opioids.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy